Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5 (Q9578)
Revision as of 15:37, 21 May 2020 by Admin (talk | contribs) (Created claim: Property:P105: 561-566, #quickstatements; #temporary_batch_1590074839150)
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kiladjian JJ
0 references
2012
0 references
Hematol. Am. Soc. Hematol. Educ. Program
0 references
2012
0 references
The spectrum of JAK2-positive myeloproliferative neoplasms (English)
0 references
561-566
0 references